Clinical Trial Update: Clinical Study About the Role of COX-2 Inhibitor in Liver Cirrhosis With Biliary Atresia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating a COX-2 inhibitor in biliary atresia with liver cirrhosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Atresia
• Liver Cirrhosis

Drugs mentioned

• COX-2 inhibitor (COX-2 inhibitor)

Snippet

Sponsor: Yonsei University | Conditions: Biliary Atresia, Kasai Portoenterostomy Status | Phase 4 | Status: COMPLETED